Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers

MORRISVILLE, N.C., May 19, 2022 -- (Healthcare Sales & Marketing Network) -- Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the closing of a $37 million Series A financing led by Kineticos Ve... Biopharmaceuticals, Venture Capital Inceptor Bio
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news